Showing results 1 to 4 of 4
Title | Author(s) | Issue Date | |
---|---|---|---|
2015 | |||
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer Journal:The New England Journal of Medicine | 2017 | ||
Adjuvant Trastuzumab in HER2-Positive Breast Cancer Journal:New England Journal of Medicine | 2011 | ||
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer Journal:New England Journal of Medicine | von Minckwitz, GHuang, CSMano, MSLoibl, SMamounas, EPUntch, MWolmark, NRastogi, PSchneeweiss, ARedondo, AFischer, HHJacot, WConlin, AKArce-Salinas, CWapnir, ILJackisch, CDiGiovanna, MPFasching, PACrown, JPWülfing, PShao, ZRota Caremoli, EWu, HLam, LHTesarowski, DSmitt, MDouthwaite, HSingel, SMGeyer, CEThe KATHERINE InvestigatorsKwong, A | 2019 |